p.69 抽出テキスト

文献

1 日本循環器学会.循環器病の診断と治療に関するガイドライン(2008 年度合同研究班報告):不整脈薬物治療に関するガイドライ

ン(2009 年改訂版). 2. 日本循環器学会.循環器病の診断と治療に関するガイドライン(2012 年度合同研究班報告):心房細動治療(薬物)ガイドライン(2013 年改訂版). 3. 日本循環器学会/ 日本不整脈心電学会.不整脈薬物治療ガイドライン(2020 年改訂版).https://www.j-circ.or.jp/cms/wp-content/ uploads/2020/01/JCS2020_Ono.pdf 4. 日本循環器学会.循環器病の診断と治療に関するガイドライン(2010 年度合同研究班報告):不整脈の非薬物治療ガイドライン(2011 年改訂版). 5. 日本循環器学会/ 日本不整脈心電学会.不整脈非薬物治療ガイドライン(2018 年改訂版).https://www.j-circ.or.jp/cms/wp-content/ uploads/2018/07/JCS2018_kurita_nogami.pdf 6. 日本循環器学会/ 日本不整脈心電学会.2021 年JCS/JHRS ガイドライン フォーカスアップデート版 不整脈非薬物治療.https:// www.j-circ.or.jp/cms/wp-content/uploads/ 2021/ 03/JCS 2021_ Kurita_Nogami.pdf 7. 総務省消防庁.令和3 年版 救急救助の現況.https://www.fdma. go.jp/publication/rescue/post-3.html 8. 日本循環器学会/ 日本不整脈心電学会.2022 年改訂版 不整脈の診断とリスク評価に関するガイドライン.https://www.j-circ.or.jp/ cms/wp-content/uploads/2022/03/JCS2022_Takase.pdf 9. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877- 883. PMID: 11907286 10. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. PMID: 15659722 11. Køber L, Thune JJ, Nielsen JC, et al. DANISH Investigators. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016; 375: 1221- 1230. PMID: 27571011 12. Golwala H, Bajaj NS, Arora G, et al. Implantable cardioverterdefibrillator for nonischemic cardiomyopathy: an updated meta-analysis. Circulation 2017; 135: 201-203. PMID: 27993908 13. Sasaki S, Noda T, Okumura K, et al. Effectiveness of implantable cardioverter defibrillator in patients with non-ischemic heart failure with systolic dysfunction ― subanalysis of the Nippon Storm Study. Circ J 2022; 87: 92-100. PMID: 35922910 14. Aonuma K, Ando K, Kusano K, et al. HINODE Investigators. Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE). ESC Heart Fail 2022; 9: 1584-1596. PMID: 35365936 15. Moss AJ, Schuger C, Beck CA, et al. MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275- 2283. PMID: 23131066 16. Zakine C, Garcia R, Narayanan K, et al. Prophylactic implantable cardioverter-defibrillator in the very elderly. Europace 2019; 21: 1063-1069. PMID: 30891608 17. Younis A, Goldberger JJ, Kutyifa V, et al. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. Eur Heart J 2021; 42: 1676-1684. PMID: 33417692 18. Zabel M, Willems R, Lubinski A, et al. EU-CERT-ICD Study Investigators. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study. Eur Heart J 2020; 41: 3437- 3447. PMID: 32372094 19. Elming MB, Nielsen JC, Haarbo J, et al. Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure. Circulation 2017; 136: 1772-1780. PMID: 28877914 20. Savelieva I, Fumagalli S, Kenny RA, et al. EHRA expert

consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace 2023; 25: 1249- 1276. PMID: 37061780 21 Green AR, Leff B, Wang Y, et al. Geriatric conditions in patients

undergoing defibrillator implantation for prevention of sudden cardiac death: prevalence and impact on mortality. Circ Cardiovasc Qual Outcomes 2016; 9: 23-30. PMID: 26715650 22. Chen MY, Orkaby AR, Rosenberg MA, et al. Frailty, implantable cardioverter defibrillators, and mortality: a systematic review. J Gen Intern Med 2019; 34: 2224-2231. PMID: 31264082 23. Poupin P, Bouleti C, Degand B, et al. Prognostic value of Charlson Comorbidity Index in the elderly with a cardioverter defibrillator implantation. Int J Cardiol 2020; 314: 64-69. PMID: 32291172 24. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. PMID: 3558716 25. Dauw J, Martens P, Nijst P, et al. The MADIT-ICD benefit score helps to select implantable cardioverter-defibrillator candidates in cardiac resynchronization therapy. Europace 2022; 24: 1276- 1283. PMID: 35352116 26. Zheng ZJ, Croft JB, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104: 2158-2163. PMID: 11684624 27. Berdowski J, Berg RA, Tijssen JG, et al. Global incidences of out-of-hospital cardiac arrest and survival rates: systematic review of 67 prospective studies. Resuscitation 2010; 81: 1479- 1487. PMID: 20828914 28. Ueda N, Noda T, Kusano K, et al. Use of implantable cardioverterdefibrillators for primary prevention of sudden cardiac death in Asia. JACC Asia 2023; 3: 335-345. PMID: 37323866 29. Fukuoka R, Kawamura A, Kohsaka S. Prediction of sudden arrhythmic death in patients with heart failure: towards validation in a worldwide broader range of patients. Eur Heart J 2021; 42: 4772-4773. PMID: 33734360 30. Younis A, Goldenberg I. Extending the MADIT-ICD benefit score to heterogenous heart failure populations. Eur Heart J 2021; 42: 4774-4775. PMID: 33734323 31. Shadman R, Poole JE, Dardas TF, et al. A novel method to predict the proportional risk of sudden cardiac death in heart failure: derivation of the Seattle Proportional Risk Model. Heart Rhythm 2015; 12: 2069-2077. PMID: 26142301 32. Bilchick KC, Wang Y, Cheng A, et al. Seattle heart failure and proportional risk models predict benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol 2017; 69: 2606- 2618. PMID: 28545633 33. Fukuoka R, Kohno T, Kohsaka S, et al. Prediction of sudden cardiac death in Japanese heart failure patients: international validation of the Seattle proportional risk model. Europace 2020; 22: 588-597. PMID: 32155253 34. Tanno K, Miyoshi F, Watanabe N, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005; 69: 19-22. PMID: 15635196 35. Shiga T, Hagiwara N, Ogawa H, et al. Heart Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) Investigators. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry. Heart 2009; 95: 216-220. PMID: 18728065 36. Satake H, Fukuda K, Sakata Y, et al. CHART- 2 Investigators. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure--a report from the CHART-2 Study. Circ J 2015; 79: 381-390. PMID: 25476195 37. van Welsenes GH, van Rees JB, Borleffs CJ, et al. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 2011; 13: 389-394. PMID: 21208947 38. Kondo Y, Noda T, Sato Y, et al. Comparison of 2-year outcomes between primary and secondary prophylactic use of defibrillators in patients with coronary artery disease: a prospective propensity score-matched analysis from the Nippon Storm Study. Heart Rhythm O2 2021; 2: 5-11. PMID: 34113899 39. Kabutoya T, Mitsuhashi T, Shimizu A, et al. Prognosis of Japanese patients with coronary artery disease who underwent implantable cardioverter defibrillator implantation ― The JID-CAD Study. Circ Rep 2021; 3: 69-76. PMID: 33693292 40. An Y, Ando K, Soga Y, et al. Mortality and predictors of appro-